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ABSTRACT
Cannabis use is associated with many negative consequences. Identification of factors
associated with cannabis could inform prevention and treatment efforts. Social anxiety appears to
be one risk factor for cannabis-related problems. Thus, it is important to identify malleable
cognitive vulnerability factors that may play a role in the social anxiety-cannabis problems
relationship. Anxiety sensitivity (AS) is the fear of anxiety-related bodily sensations and is
composed of three subfacets: physical, cognitive, and social concerns. AS is associated with
greater social anxiety and may play a role in cannabis-related impairment. Intolerance of
uncertainty (IU) refers to a tendency to respond negatively to uncertain situations. IU is
associated with social anxiety and may play a role in cannabis-related problems. The current
study sought to examine the associations of AS subfacets and IU with cannabis problems as well
as the direct and indirect (via AS subfacets and IU) effects of social anxiety on cannabis
problems among 220 current (i.e., past three-month) cannabis users. Consistent with prior
research, social anxiety was positively related to cannabis problems. All AS subfacets and IU
were positively related to cannabis problems. Social anxiety was indirectly related to cannabis
problems through AS-social concerns and IU but not through AS-physical concerns or AScognitive concerns. When AS-social concerns and IU were tested simultaneously, social anxiety
remained indirectly related to cannabis problems only through IU. Results highlight the
importance of considering IU in treatment efforts for individuals experiencing cannabis-related
impairment.
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CHAPTER 1: INTRODUCTION
1.1 Cannabis
Cannabis is the most commonly used illicit drug in the United States with 7.5% of
individuals aged 12 or older reporting past-month use and approximately one in four users
experiencing enough distress and/or impairment related to their use that a diagnosis of cannabis
use disorder (CUD) is warranted (Substance Abuse and Mental Health Services Administration,
2014). Further, rates of CUD have risen over the past decade (Compton, Grant, Colliver, Glantz,
& Stinson, 2004). Cannabis use is associated with a number of negative health consequences
(e.g., chronic respiratory tract symptoms such as coughing and wheezing; Bloom, Kaltenborn,
Paoletti, Camilli, & Lebowitz, 1987; Tashkin, 1990), poorer educational outcomes (e.g., lower
GPA; for review see Lynskey & Hall, 2000), and an increase in risky behaviors (e.g., seat belt
disuse; Begg & Langley, 2000; Shrier, Emans, Woods, & DuRant, 1997). Further,
discontinuation of cannabis use is associated with a number of withdrawal symptoms (e.g.,
increases in anxiety and irritability and decreases in appetite; Kouri & Pope, 2000). Given that
cannabis use is associated with a number of negative outcomes, it is important to understand
variables related to cannabis use and use-related problems. Such knowledge could inform
treatment and prevention efforts.
1.2 Social Anxiety and Cannabis
Social anxiety has been identified as one risk factor for cannabis-related impairment (for
review see Buckner, Heimberg, Ecker, & Vinci, 2013; Buckner et al., 2008). Social anxiety
disorder (SAD) is characterized by a marked or intense fear of social situations in which the
individual may be scrutinized or evaluated by others (American Psychiatric Association, 2013).
Among individuals with a lifetime diagnosis of cannabis dependence, the lifetime prevalence of
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SAD was found to be 29% (Agosti, Nunes, & Levin, 2002). This is much higher than the lifetime
prevalence of other anxiety disorder diagnoses (6.9% to 18.5%; Agosti et al., 2002). Further, the
lifetime prevalence of SAD in individuals diagnosed with cannabis dependence is much higher
than the 12-month prevalence of SAD diagnosis within the general population (6.8%; Kessler,
Chiu, Demler, & Walters, 2005). Findings from one longitudinal study indicate that SAD may
show some specificity as a risk factor for developing cannabis dependence (Buckner et al.,
2008). In this study, 22% of adolescents with a diagnosis of SAD developed cannabis
dependence by age 30 compared with only 5% of adolescents with no SAD diagnosis. Further, a
diagnosis of SAD was the only anxiety disorder diagnosis related to later cannabis dependence.
This relationship remained even after controlling for other anxiety disorder diagnoses. Moreover,
epidemiological data suggest that among those with SAD and CUD, the onset of SAD precedes
the onset of CUD in the majority of individuals (Buckner, Heimberg, Schneier, et al., 2012).
Although findings are mixed in terms of the association between social anxiety and
frequency of cannabis use (Buckner, Bonn-Miller, Zvolensky, & Schmidt, 2007; Buckner, Ecker,
& Cohen, 2010; Buckner & Schmidt, 2008; Ecker, Richter, & Buckner, 2014; Griffin, Botvin,
Scheier, & Nichols, 2002; Oyefeso, 1991), there appears to be a clear relationship between social
anxiety and cannabis-related problems (Buckner, Heimberg, Matthews, & Silgado, 2012;
Buckner & Schmidt, 2008; Buckner et al., 2008; Ecker et al., 2014; Lynskey et al., 2002).
Among nonclinical samples, social anxiety is incrementally associated with cannabis-related
problems after controlling for other relevant variables (e.g., cannabis use frequency, alcohol use
disorder symptoms, major depressive disorder, other anxiety disorders; Buckner, Mallott,
Schmidt, & Taylor, 2006; Buckner & Schmidt, 2009; Buckner, Schmidt, Bobadilla, & Taylor,
2006). Further, SAD is associated with faster transition from first use to experiencing cannabis-
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related problems among adolescent boys (Marmorstein, White, Loeber, & Stouthamer-Loeber,
2010) and among men (Buckner, Heimberg, Schneier, et al., 2012). Additionally, SAD is more
strongly associated with cannabis dependence than cannabis abuse (Buckner, Heimberg,
Schneier, et al., 2012; Buckner et al., 2008), suggesting that individuals with SAD may have a
higher risk for developing more severe problems related to their cannabis use.
Despite high rates of co-occurring social anxiety and cannabis-related problems, little
empirical work has been done to elucidate the nature of this relationship. Consistent with
tension-reduction theory (Conger, 1956), individuals with social anxiety may use cannabis to
cope with their chronically elevated anxiety, and using cannabis in this way may increase their
risk for developing cannabis-related problems (cf. Buckner, Heimberg, Matthews, et al., 2012).
In line with this hypothesis, among cannabis using young adults, social anxiety was related to
using cannabis to cope with negative affect, which mediated the relationship between social
anxiety and cannabis-related problems (Buckner, Bonn-Miller, et al., 2007). Individuals with
elevated social anxiety were more likely to use cannabis in social situations and to avoid these
situations if cannabis was not available (Buckner, Heimberg, Matthews, et al., 2012). Further,
using cannabis in social situations mediated the relationship between social anxiety and
cannabis-related problems. During a public speaking challenge, individuals with SAD reported
greater craving of cannabis than those without SAD (Buckner, Silgado, & Schmidt, 2011) and
participants who completed a social interaction task reported greater cannabis craving than those
who completed a neutral reading task (Buckner, Ecker, & Vinci, 2013).
Taken together, these data suggest that there is a robust relationship between social
anxiety and problematic cannabis use, yet some studies have yielded inconsistent results. For
example, social anxiety and SAD were not associated with the expectation that using cannabis
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would result in reductions in negative affect (Buckner & Schmidt, 2008, 2009). Given these
inconsistencies, it may be that other variables play a role in the relationship between social
anxiety and cannabis-related problems. An important next step is to elucidate mechanisms by
which the social anxiety-cannabis problems relationship may function.
1.3 Potential Mediators of the Social Anxiety-Cannabis Problems Relationship
1.3.1 Anxiety Sensitivity. Anxiety sensitivity (AS) is a malleable (Otto, Pollack, Fava,
Uccello, & Rosenbaum, 1995; Schmidt et al., 2007), relatively stable (Rodriguez, Bruce, Pagano,
Spencer, & Keller, 2004) risk factor (Zvolensky, Schmidt, Bernstein, & Keough, 2006) that
reflects a fear of anxiety-related sensations due to beliefs that these sensations have detrimental
physical, psychological, or social consequences (McNally, 2002). For example, an individual
with high AS who experiences a racing heart might believe this sensation is a sign of a heart
attack. On the other hand, individuals with low AS may believe this sensation is unpleasant, but
benign (Taylor, Koch, & McNally, 1992). AS is composed of one higher order factor (i.e., global
AS) with three correlated lower order factors: physical concerns (i.e., fear of physical symptoms
of anxiety, such as heart palpitations), cognitive concerns (i.e., fear of cognitive symptoms of
anxiety, such as racing thoughts), and social concerns (i.e., fear of publicly observable symptoms
of anxiety, such as blushing; Taylor et al., 2007). AS is distinctive from trait anxiety (Taylor,
Koch, & Crockett, 1991) and is thought to amplify anxiety responses (Reiss, 1991). In other
words, when people with high AS get anxious, they become anxious about a feared stimulus and
their own anxiety, which further exacerbates their anxiety reaction (cf. Collimore & Asmundson,
2014).
Although early work implicated AS in the etiology and maintenance of panic disorder
(McNally, 2002; Reiss, 1991; Taylor et al., 1992), it has since been shown that elevated levels of
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AS are associated with numerous other forms of psychopathology (Deacon & Abramowitz,
2006; Otto et al., 1995; Taylor, 1999), including SAD/social phobia (Asmundson & Stein, 1994;
Deacon & Abramowitz, 2006; Harvey, Richards, Dziadosz, & Swindell, 1993; Orsillo,
Lilienfeld, & Heimberg, 1994; Rodriguez et al., 2004; Taylor et al., 1992). Further, AS was
incrementally associated with social performance anxiety and social interaction anxiety among
university students after controlling for other relevant factors (e.g., neuroticism, anxiety,
depression, gender, negative affect; Keough, Riccardi, Timpano, Mitchell, & Schmidt, 2010;
Norr et al., 2013; Norton, Cox, Hewitt, & McLeod, 1997). Moreover, all three AS subfacets have
been found to be positively correlated with social anxiety in both clinical and non-clinical
samples (Allan, Capron, Raines, & Schmidt, 2014; Belcher & Peters, 2009; Grant, Beck, &
Davila, 2007; Noel, Lewis, Francis, & Mezo, 2013; Wheaton, Deacon, McGrath, Berman, &
Abramowitz, 2012).
It has been posited that AS is important in the development and maintenance of substance
use and related problems (cf. Reiss, 1991). Consistent with tension-reduction theory (Conger,
1956), individuals with elevated AS may utilize drugs/alcohol to cope with their heightened
levels of anxious responding (Reiss, 1991; Stewart & Kushner, 2001). In line with this
hypothesis, AS was incrementally associated with coping motives for cannabis use after
controlling for other relevant variables among adult current cannabis users (e.g., frequency of
cannabis use, frequency of alcohol use, negative affectivity, other motives for cannabis use;
Bonn-Miller, Zvolensky, & Bernstein, 2007; Hecimovic, Barrett, Darredeau, & Stewart, 2014;
Johnson, Mullin, Marshall, Bonn‐Miller, & Zvolensky, 2010; Smits, Bonn-Miller, Tart, Irons, &
Zvolensky, 2011; Zvolensky et al., 2009) and adult daily cigarette smokers (Norberg, Olivier,
Schmidt, & Zvolensky, 2014). Further, among female undergraduate students, AS was

5

significantly associated with the use of alcohol and drugs to cope with anxiety and depression
(Stewart, Karp, Pihl, & Peterson, 1997). Moreover, AS was significantly associated with
coping-motivated cannabis use among adolescents (Comeau, Stewart, & Loba, 2001).
Emerging data suggests that global AS may not be associated with cannabis-related
problems (Buckner, Bonn-Miller, et al., 2007); rather, the AS subfacets may be differentially
related to cannabis-related problems. In an ecological momentary assessment that monitored
antecedents of subsequent cannabis use, the AS-cognitive concerns subfacet (but not global AS
or the physical or social concerns subfacets) was associated with severity of cannabis-related
problems at baseline (Buckner, Zvolensky, et al., 2011). Further, the AS-cognitive concerns
subfacet and the AS-social concerns subfacet each interacted with cannabis craving to predict
subsequent cannabis use (Buckner, Zvolensky, et al., 2011). Further, among adult current
cannabis users, AS was robustly related to cannabis withdrawal symptoms after controlling for
relevant factors (e.g., past month cannabis use) and this was especially true for AS-cognitive
concerns (Bonn-Miller, Zvolensky, Marshall, & Bernstein, 2007). Although global AS has been
found to be unrelated to cannabis-related problems, it appears that the specific subfacets of AS
are related to cannabis-related problems.
Consistent with prior research on psychological factors and substance use (Simons, 2003;
Simons & Gaher, 2005), AS does not appear to be associated with level or frequency of
drug/alcohol use. Among a sample of undergraduate students, levels of AS did not significantly
differ between individuals who reported drug/alcohol use in the past 30 days and those who
denied drug/alcohol use in the past 30 days (Stewart et al., 1997). Among adult regular cigarette
smokers, AS was not associated with status or frequency of cannabis use (Buckner, Zvolensky,
Jeffries, & Schmidt, 2014; Norberg et al., 2014; Zvolensky, Bonn-Miller, et al., 2006). Further,
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among adolescents, AS was not associated with a lifetime prevalence of cannabis use (Malmberg
et al., 2010). Global AS and AS subfacets were unrelated to cannabis use frequency among adult
cannabis users (Bonn-Miller, Zvolensky, & Bernstein, 2007; Bonn-Miller, Zvolensky, Marshall,
et al., 2007; Buckner, Bonn-Miller, et al., 2007; Buckner, Zvolensky, et al., 2011; Zvolensky et
al., 2009). Interestingly, it seems that levels of AS may actually be lower in individuals who use
cannabis/hashish and report cannabis as their drug of choice (Norton, Rockman, et al., 1997;
Stewart et al., 1997). Taken together, it seems that AS is unrelated to level or frequency of
substance use in general, and cannabis use more specifically.
Consistent with tension-reduction theory (Conger, 1956), and given that AS is related to
coping motives for cannabis use (e.g., Bonn-Miller, Zvolensky, & Bernstein, 2007), which are
associated with cannabis-related problems (Buckner, Bonn-Miller, et al., 2007), it follows that at
least some aspects of AS may be associated with cannabis-related problems. Emerging data
suggest that the AS-cognitive concerns subfacet may be especially related to cannabis-related
problems and withdrawal (Bonn-Miller, Zvolensky, Marshall, et al., 2007; Buckner, Zvolensky,
et al., 2011). Given that only one known study has examined the relationship between AS
subfacets and cannabis-related problems specifically, replication is necessary to confirm that the
AS-cognitive concerns subfacet is associated with cannabis-related problems.
1.3.2 Intolerance of Uncertainty. Another anxiety-related vulnerability factor is
intolerance of uncertainty (IU), which is conceptually related to AS, yet distinct (Carleton,
Sharpe, & Asmundson, 2007). IU is a malleable (Boswell, Thompson-Hollands, Farchione, &
Barlow, 2013; Dugas & Ladouceur, 2000; Ladouceur, Gosselin, & Dugas, 2000; Mahoney &
McEvoy, 2012) cognitive vulnerability factor that affects how a person perceives, interprets, and
responds to uncertain situations (Dugas, Schwartz, & Francis, 2004). More specifically,
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individuals who are intolerant of uncertainty believe that uncertainty is stressful and that
uncertain situations should be avoided (Buhr & Dugas, 2002). IU is related to worry, yet distinct,
and is seen as an antecedent to worry (Buhr & Dugas, 2002; Ladouceur, Talbot, & Dugas, 1997).
Further, manipulation of IU affects worry, which suggests that IU is causally associated with
worry (Ladouceur et al., 2000).
Although early work implicated IU in the etiology and maintenance of worry and
generalized anxiety disorder (Buhr & Dugas, 2006; GAD; Dugas, Buhr, & Ladouceur, 2004;
Dugas, Freeston, & Ladouceur, 1997; Dugas, Marchand, & Ladouceur, 2005; Dugas, Schwartz,
et al., 2004), it has since been posited that it is a fundamental component of all anxiety disorders
(cf. Carleton et al., 2007). Indeed, recent empirical work has demonstrated that IU may be an
important factor in other anxiety disorders (Carleton et al., 2014; Holaway, Heimberg, & Coles,
2006; Tolin, Abramowitz, Brigidi, & Foa, 2003; Yook, Kim, Suh, & Lee, 2010), including SAD
(Boelen & Reijntjes, 2009; Boelen, Vrinssen, & van Tulder, 2010).
Among nonclinical samples, IU has been found to be incrementally associated with social
anxiety and social avoidance after controlling for a number of theoretically relevant variables
(e.g., neuroticism, fear of negative evaluation, anxiety sensitivity, gender, negative affectivity,
trait anxiety; Boelen & Reijntjes, 2009; Carleton, Collimore, & Asmundson, 2010; Norr et al.,
2013). Among undergraduate students, IU was incrementally associated with social interaction
and social performance anxiety after controlling for fear of negative evaluation and worry
(Whiting et al., 2014). Further, among adolescents, IU was robustly associated with social
anxiety after controlling for negative affectivity, gender, and age (Boelen et al., 2010).
Although there seems to be a robust association between IU and social anxiety in
nonclinical samples, findings among clinical samples have been mixed. For example, one study
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found that IU was not correlated with social interaction anxiety among individuals diagnosed
with an anxiety and/or depressive disorder (Boswell et al., 2013). Yet, findings from another
study indicated that individuals with SAD had significantly higher levels of IU than
undergraduate students and community participants (Carleton et al., 2012). Taken together, these
data suggest that IU may play an important role in the development and maintenance of SAD.
Consistent with tension-reduction theory (Conger, 1956) and recent work finding that IU
is associated with coping motives for alcohol use (Kraemer, McLeish, & O'Bryan, 2015;
Oglesby, Albanese, Chavarria, & Schmidt, 2015), IU may be associated with cannabis-related
problems. Yet, no known studies have examined the relationship between IU and cannabis use or
related problems. It is plausible that individuals who cannot tolerate uncertainty may use
cannabis to cope with ambiguous situations. This might be particularly relevant for socially
anxious individuals, given that uncertainty is inherent in social situations (cf. Boelen & Reijntjes,
2009).
1.4 Current Study and Aims
The current study set out to fill gaps in the literature on social anxiety and cannabis use
and related problems in several ways. First, the study aimed to examine if social anxiety is
related to frequency of cannabis use. Given that the majority of prior work has found no relation
between social anxiety and cannabis use frequency (Buckner, Bonn-Miller, et al., 2007; Buckner
et al., 2010; Buckner & Schmidt, 2008; Ecker et al., 2014), it was hypothesized that we would
replicate this finding. Second, the study aimed to replicate prior work (e.g., Buckner, Heimberg,
Matthews, et al., 2012; Buckner & Schmidt, 2008; Buckner et al., 2008; Ecker et al., 2014;
Lynskey et al., 2002) that social anxiety is positively related to cannabis problems. Third, the
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study aimed to replicate prior work that social anxiety is related to AS subfacets (Allan et al.,
2014; Belcher & Peters, 2009; Grant et al., 2007; Noel et al., 2013; Wheaton et al., 2012) and IU
(e.g., Boelen & Reijntjes, 2009; Carleton et al., 2010; Whiting et al., 2014).
Fourth, the study aimed to replicate prior work (Bonn-Miller, Zvolensky, Marshall, et al.,
2007) that AS subfacets are unrelated to frequency of cannabis use. Fifth, the study aimed to
elucidate the relation of AS subfacets with cannabis problems. Consistent with tension-reduction
theory (Conger, 1956) and past work (Buckner, Zvolensky, et al., 2011), we hypothesized that
AS-cognitive concerns would be positively related to cannabis problems. Sixth, the study aimed
to examine the relation of IU and cannabis use frequency. It was hypothesized that IU would be
unrelated to cannabis use frequency given that extant work has found no relation between other
psychological factors and cannabis or other substance use frequency (Bonn-Miller, Zvolensky, &
Bernstein, 2007; Buckner, Bonn-Miller, et al., 2007; Buckner, Zvolensky, et al., 2011; Simons &
Gaher, 2005; Zvolensky et al., 2009). Seventh, the study aimed to examine the association
between IU and cannabis-related problems. In line with tension-reduction theory (Conger, 1956),
it was hypothesized that IU would be positively related to cannabis problems.
Eighth, this study aimed to elucidate the relationship between social anxiety and cannabis
problems by examining the mediational roles of AS subfacets and IU in the social anxietycannabis problems relationship. It was hypothesized that social anxiety would be indirectly
related to cannabis problems through AS-cognitive concerns and IU. Given that prior work has
observed gender differences in the social anxiety-cannabis problems relationship (Buckner,
Mallott, et al., 2006), gender was assessed as a possible covariate to be included in the analyses.
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Additionally, depression and cannabis use frequency were assessed as possible covariates given
their associations with cannabis problems (e.g., Buckner, Bonn-Miller, et al., 2007; Buckner,
Keough, & Schmidt, 2007).
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CHAPTER 2: METHOD
2.1 A Priori Power Analysis and Sample Size
The sample size necessary to achieve the recommended power of .80 (J. Cohen, 1988)
was determined using the guidelines proposed by Fritz and MacKinnon (2007). Previous work
investigating factors that may mediate the relationship between social anxiety and cannabisrelated problems have observed effect sizes between small and small-to-medium for path α (i.e.,
the effect of X on M) and between small to medium and medium for path β (i.e., the effect of M
on Y; Buckner, Bonn-Miller, et al., 2007; Buckner, Heimberg, Matthews, et al., 2012; Buckner
& Schmidt, 2009; Buckner, Zvolensky, & Schmidt, 2012). Thus, the sample size necessary to
detect small-to-medium effects for path α and path β was determined. The sample necessary to
achieve .80 power and to detect small-to-medium effect sizes in maximum likelihood
bootstrapping for testing indirect effects is 162 participants. Thus, our final sample of 220 should
be sufficient to test study hypotheses.
2.2 Sample and Procedures
The sample was composed of undergraduate students recruited through psychology
classes for research participation credit at Louisiana State University (LSU). Inclusion criteria
for the current study included being an undergraduate student at LSU enrolled in a psychology
course, being at least 18 years of age, and endorsing current (i.e., past three-month) cannabis use.
Although 844 participants began the survey, 624 were excluded from the current study due to:
being under the age of 18 (n = 4), not completing the entire survey (n = 52), and denial of past
three-month cannabis use (n = 568). The final sample consisted of 220 (77.7 % female) current
(i.e., past three-month) cannabis-users. The mean age of participants was 20.18 (SD = 2.15,
ranged from 18 to 40). The racial/ethnic composition was 12.7 % non-Hispanic African
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American or Black, 0.5% Hispanic African American or Black, 0.9% American Indian or Alaska
Native, 2.3% Asian, 77.3% non-Hispanic Caucasian, 0.9% Hispanic Caucasian, 4.1%
multiracial, and 1.4% “other”.
Participants signed up for the survey using the LSU psychology department’s online
survey sign-up system. Once enrolled, participants completed a battery of self-report measures
(see Measures section) online using a secure data collection website, www.surveymonkey.com.
Data were collected between January 2014 and October 2014. The University’s Institutional
Review Board approved this study prior to data collection. Participants were first asked to
provide informed consent, and then begin the self-report measures. Data are stored on a secure
server in Dr. Buckner’s research laboratory in 105 Audubon Hall on LSU’s campus.
Participants’ responses were identified by ID numbers to preserve confidentiality. A certificate
of confidentiality was obtained from the National Institute on Drug Abuse to further ensure
security and confidentiality.
2.3 Measures
2.3.1 Marijuana Use Form (MUF; Buckner, Bonn-Miller, et al., 2007). The MUF was
used to assess current (i.e., past three month) cannabis use. Participants rated their cannabis use
on a 0 (less than once a month) to 10 (21 or more times a week) scale. The MUF has
demonstrated good convergent validity with other measures of cannabis use (Buckner, Crosby,
Wonderlich, & Schmidt, 2012).
2.3.2 Marijuana Problems Scale (MPS; Stephens, Roffman, & Curtin, 2000). The MPS
is a self-report questionnaire used to assess 19 negative consequences associated with cannabis
use (i.e., cannabis-related problems) in the past 90 days. Participants rated the degree to which
marijuana has caused problems (e.g., “Problems in your family”) on a 0 (no problem) to 2
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(serious problem) scale. Number of problems was calculated by totaling the number of problems
participants endorse. The MPS has demonstrated good internal consistency (Stephens et al.,
2004). This measure demonstrated an adequate level of internal consistency (α = .76) in the
current sample.
2.3.3 Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998). The SIAS is a
20-item self-report questionnaire used to assess social interaction fears. Participants rated items
(e.g., “I have difficulty making eye contact with others”) on a 0 (not at all) to 4 (extremely) scale.
The SIAS has shown excellent internal consistency, discriminant validity, and construct validity
(Mattick & Clarke, 1998). The measure demonstrated a good level of internal consistency (α =
.89) in the current sample. Further, the SIAS has consistently been found to be associated with
cannabis-related problems (e.g., Buckner, Heimberg, Matthews, et al., 2012; Buckner &
Schmidt, 2008; Buckner, Zvolensky, et al., 2012; Najolia, Buckner, & Cohen, 2012).
2.3.4 Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007). The ASI-3 is an 18-item
self-report questionnaire used to assess the physical, cognitive, and social factors of AS.
Participants rated items on a 0 (very little) to 4 (very much) scale. The ASI-3 is composed of
three subscales corresponding with the lower-order factors of AS. Example items from the
physical, cognitive, and social subscales include: “It scares me when my heart beats rapidly”, “It
scares me when I am unable to keep my mind on tasks”, and “It scares me when I blush in front
of people”. The ASI-3 subscales have shown good to excellent internal consistency, convergent
validity, and discriminant validity (Norr et al., 2013; Taylor et al., 2007). In the current sample,
the ASI-3 total score (α = .93) and cognitive concerns subscale (α = .91) demonstrated excellent
internal consistency, the physical concerns subscale achieved good internal consistency (α = .88)
and the social concerns subscale achieved acceptable internal consistency (α = .74).
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2.3.5 Intolerance of Uncertainty Scale (IUS; English version: Buhr & Dugas, 2002;
Original French version: Freeston, Rhéaume, Letarte, Dugas, & Ladouceur, 1994). The IUS is a
27-item self-report questionnaire used to assess IU. Participants rated items (e.g., “Uncertainty
makes me uneasy, anxious, or stressed”) on a 1 (not at all characteristic of me) to 5 (entirely
characteristic of me) scale. The IUS has shown excellent internal consistency, test-retest
reliability, convergent validity, and discriminant validity (Buhr & Dugas, 2002; Norr et al.,
2013). The measure demonstrated an excellent level of internal consistency (α = .96) in the
current sample.
2.3.6 Depression Anxiety Stress Scale-21 (DASS-21; Antony, Bieling, Cox, Enns, &
Swinson, 1998). The DASS-21 is a 21 item self-report questionnaire used to assess depression,
anxiety, and stress. The depression subscale of this measure was used to control for depression.
Participants rated the degree to which they have experienced negative emotional symptoms (e.g.,
“I felt down-hearted and blue”) in the past week on a 1 (Did not apply to me at all) to 4 (Applied
to me very much, or most of the time) scale. The DASS-21 depression subscale has demonstrated
excellent internal consistency (Antony et al., 1998). The measure achieved a good level of
internal consistency (α = .83) in the current sample.
2.3.7 Infrequency Scale (IS; Chapman & Chapman, 1983). To identify random
responders who may have provided random or grossly invalid responses, four questions (e.g., “I
find that I often walk with a limp, which is the result of a skydiving accident”) from the IS were
included. As in prior online studies (e.g., A. Cohen, Iglesias, & Minor, 2009), individuals who
endorsed three or more infrequency items were considered random responders and were
excluded from the study (n = 0).
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2.4 Data Analytic Strategy
First, we examined if any covariates needed to be included in the analyses by conducting
correlation analyses between depression, cannabis use frequency, cannabis-related problems, and
social anxiety. Analysis of variance (ANOVA) was used to determine if gender was
differentially related to social anxiety or cannabis-related problems. To test the first and second
hypotheses that social anxiety would be unrelated to cannabis use frequency, yet related to
cannabis-related problems, correlation analyses were conducted between social anxiety, cannabis
use frequency, and number of cannabis-related problems. To test the third hypothesis that social
anxiety would be related to AS subfacets and IU, correlation analyses were conducted between
social anxiety, AS subfacets, and IU.
To test the fourth and fifth hypotheses, that AS subfacets would be unrelated to cannabis
use frequency yet AS-cognitive concerns would be related to cannabis-related problems,
correlation analyses were conducted between AS subfacets, cannabis use frequency, and number
of cannabis-related problems. To test the sixth and seventh hypotheses that IU would be
unrelated to cannabis use frequency yet related to cannabis-related problems, correlation
analyses were conducted between IU, cannabis use frequency, and number of cannabis-related
problems.
To examine the eighth hypothesis that social anxiety would be indirectly related to
cannabis problems through AS-cognitive concerns and IU, analyses were conducted using
PROCESS, a macro used with SPSS 23.0 that utilizes an ordinary least squares regression-based
path analytical framework to test for both direct and indirect effects (Hayes, 2013), using
bootstrap analyses with 10,000 resamples from which bias-corrected 95-percentile confidence
intervals (CI) were estimated (Hayes, 2009; Preacher & Hayes, 2004, 2008). In a simple
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mediation model, the total effect is the effect of X on Y, which includes direct and indirect
effects. The direct effect (c’) is the portion of the effect of X on Y independent of the effect of X
on Y through the mediator (M). The indirect effect is the difference between the total and direct
effects and is used to test mediation. X is indirectly related to Y through M if the bias-corrected
bootstrap confidence intervals for the indirect effect do not cross zero (Hayes, 2013).
Statisticians assert that a significant direct effect of X on Y is not necessary to establish mediation
given that X can be causally related to Y indirectly through M (Hayes, 2009, 2013). We planned
to test five models. Specifically, we planned to test the effects of each AS subfacet (i.e., ASphysical concerns, AS-cognitive concerns, AS-social concerns), IU, and AS-cognitive concerns
and IU simultaneously.
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CHAPTER 3: RESULTS
3.1 Sample Characteristics and Correlations Between Study Variables
Participants used cannabis on average two or three times during the past month, 36% of
participants used cannabis weekly, and 9.1% of participants used daily. See Table 1 for means,
standard deviations, and correlations between study variables. Consistent with hypothesis, social
anxiety was unrelated to cannabis use frequency, yet positively correlated with number of
cannabis-related problems. Consistent with hypothesis, social anxiety was significantly
positively correlated with all AS subfacets and IU. Consistent with prediction, AS subfacets were
unrelated to cannabis use frequency and AS-cognitive concerns were significantly, positively
correlated with cannabis-related problems. Counter to hypotheses, AS-physical concerns and
AS-social concerns were both significantly positively correlated with cannabis-related problems.
Also consistent with hypothesis, IU was unrelated to cannabis use frequency, yet significantly
positively correlated with cannabis-related problems. Depression was significantly correlated
with both social anxiety and cannabis-related problems and cannabis use frequency was
significantly correlated with cannabis-related problems.
Table 1. Intercorrelations, Means, and Standard Deviations for Study Variables
Measure
1
2
3
4
5
6
7
8
1. Social anxiety
.14*
2. Cannabis problems
.26* .14*
3. AS Physical
*.34* .15*
.77**
4. AS Cognitive
*
.46*
.23** .71** .68**
5. AS Social
*
.25** .45** .57**
6. Intolerance of uncertainty .39*
*
.45*
.19*
.35** .51** .59** .53**
7. Depression
*
.43**
.01
.34** .04
.09
.02
-.02
.16*
8. Cannabis use frequency
M
19.4 2.40
3.20
3.06
4.78
52.26 5.87
2.51
5
10.6
2.58
4.26
4.35
3.98
19.34 6.24
2.54
SD
8
Note. N = 220; AS = Anxiety Sensitivity;
Physical, Cognitive, and Social Concerns are subfacets
of AS.
* p < .05; ** p < .01.
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Gender was differentially related to cannabis problems, such that men (M = 3.1, SD =
3.1) endorsed more cannabis problems than women (M = 2.2, SD = 2.4), F (1, 218) = 4.8, p =
.03, d = 0.33. Given that gender was differentially related to cannabis problems, correlation
analyses were also conducted by gender (see Table 2). Social anxiety was positively correlated
with cannabis problems and cannabis use frequency among men but not women and cannabis
problems were positively correlated with AS subfacets among women but not men. Depression,
cannabis use frequency, and gender were included as covariates in subsequent analyses.
Table 2. Correlations for Study Variables Separated by Gender
1
2
3
4
5
6
7
8
Measure
.43** .22
.41**
.56** .33**
1. Social anxiety
.06
.08
.12
.23
.36* .32*
.32*
2. Cannabis problems
.42**
.60**
.72**
.43** .15
3. AS Physical
.27* .17*
.16*
.78**
4. AS Cognitive
.32*
*
.64** .57** .63** .27
.25**
.72**
.70**
5. AS Social
.46*
*
.62** .66** .47** .16
.22** .42** .55**
6. Intolerance of uncertainty .33*
*
.63** .67** .06
.14
.32** .47** .58**
.17
7. Depression
.41*
*
.03
.33**
.01
.02
-.02
-.04
.16*
8. Cannabis use frequency
*
.41** .49**
Note. AS = Anxiety Sensitivity; Physical, Cognitive, and Social Concerns are subfacets of AS.
Correlations for women (n = 171) are presented below the diagonal (shaded area). Correlations
for men (n = 49) are presented above the diagonal.
* p < .05; ** p < .01.
3.2 Tests of Direct and Indirect Effects
See Figure 1 for models testing indirect effects. The total effects model (with social
anxiety and covariates) accounted for significant variance (R2 = .15, df = 4, 215, F = 9.38, p <
.001); however, social anxiety did not account for significant variance in cannabis-related
problems (B = 0.02, SE = 0.02, p = .292, 95% CI = -0.02, 0.05) due to the variance accounted for
by depression (B = 0.04, SE = 0.03, p = .145, 95% CI = -0.01, 0.10) and cannabis use frequency
(B = 0.31, SE = 0.07, p < .001, 95% CI = 0.18, 0.44). In terms of social anxiety being indirectly
related to cannabis problems through AS-cognitive concerns (Model A), the full model with AScognitive concerns accounted for significant variance (R2 = .15, df = 5, 214, F = 7.63, p < .001);
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Figure 1. Models Depicting Direct and Indirect Effects of Social Anxiety on Cannabis-Related
Problems
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however AS-cognitive concerns did not account for significant variance in cannabis-related
problems (B = 0.04, SE = 0.04, p = .404, 95% CI = -0.05, 0.12). The direct effect of social
anxiety on cannabis problems (controlling for AS-cognitive concerns and covariates) was
nonsignificant (B = 0.02, SE = 0.02, p = .359, 95% CI = -0.02, 0.05). Regarding the test of the
indirect effect, social anxiety was not indirectly related to cannabis-related problems through
AS-cognitive concerns (B = 0.002, SE = 0.003, 95% CI = -0.003, 0.012).
In terms of social anxiety being indirectly related to cannabis problems through ASphysical concerns (Model B), the full model with AS-physical concerns accounted for significant
variance (R2 = .15, df = 5, 214, F = 7.82, p < .001); however, AS-physical concerns did not
account for significant variance in cannabis-related problems (B = 0.05, SE = 0.04, p = .219,
95% CI = -0.03, 0.13). The direct effect of social anxiety on cannabis problems (controlling for
AS-physical concerns and covariates) was nonsignificant (B = 0.02, SE = 0.02, p = .369, 95% CI
= -0.02, 0.05). Regarding the test of the indirect effect, social anxiety was not indirectly related
to cannabis-related problems through AS-physical concerns (B = 0.003, SE = 0.004, 95% CI = 0.002, 0.013).
In terms of social anxiety being indirectly related to cannabis problems through AS-social
concerns (Model C), the full model with AS-social concerns accounted for significant variance
(R2 = .18, df = 5, 214, F = 9.48, p < .001), with AS-social concerns accounting for significant
variance in cannabis-related problems (B = 0.14, SE = 0.05, p = .004, 95% CI = 0.05, 0.23). The
direct effect of social anxiety on cannabis problems (controlling for AS-social concerns and
covariates) was nonsignificant (B = 0.001, SE = 0.02, p = .958, 95% CI = -0.03, 0.04). Regarding
the test of the indirect effect, social anxiety was indirectly related to cannabis-related problems
through AS-social concerns (B = 0.02, SE = 0.01, 95% CI = 0.003, 0.035).
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In terms of social anxiety being indirectly related to cannabis problems through IU
(Model D), the full model with IU accounted for significant variance (R2 = .19, df = 5, 214, F =
10.22, p < .001), with IU accounting for significant variance in cannabis-related problems (B =
0.03, SE = 0.01, p < .001, 95% CI = 0.01, 0.05). The direct effect of social anxiety on cannabis
problems (controlling for IU and covariates) was nonsignificant (B = 0.01, SE = 0.02, p = .724,
95% CI = -0.03, 0.04). Regarding the test of the indirect effect, social anxiety was indirectly
related to cannabis-related problems through IU (B = 0.01, SE = 0.01, 95% CI = 0.003, 0.029).
Given that social anxiety was not indirectly related to cannabis-related problems through
AS-cognitive concerns, the third model (social anxiety being indirectly related to cannabis
problems through AS-cognitive concerns and IU) was not tested. Rather, given that social
anxiety was related to cannabis problems indirectly through AS-social concerns and IU, a model
examining the indirect effects of these two variables simultaneously was tested (Model E). The
full model with AS-social concerns and IU accounted for significant variance (R2 = .20, df = 6,
213, F = 9.02, p < .001), with IU (B = 0.03, SE = 0.01, p = .018, 95% CI = 0.005, 0.048)
accounting for significant variance in cannabis-related problems. AS-social concerns did not
account for significant variance in cannabis-related problems (B = 0.08, SE = 0.05, p = .105,
95% CI = -0.02, 0.19). The direct effect of social anxiety on cannabis problems (controlling for
AS-social concerns, IU, and covariates) was nonsignificant (B = -0.002, SE = 0.02, p = .925,
95% CI = --0.04, 0.03). Regarding the test of the indirect effect, the total indirect effect (with
AS-social concerns and IU) was significant (B = 0.02, SE = 0.01, 95% CI = 0.01, 0.04) such that
social anxiety was indirectly related to cannabis-related problems through IU (B = 0.01, SE =
0.01, 95% CI = 0.001, 0.025) but not AS-social concerns (B = 0.01, SE = 0.01, 95% CI = -0.003,
0.028).
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CHAPTER 4: DISCUSSION
4.1 General Discussion
This study was the first to investigate IU’s role in cannabis use and related impairment.
Further, this was the first known study to examine the indirect effects of social anxiety on
cannabis problems through AS subfacets and IU. Consistent with prediction, social anxiety was
unrelated to cannabis use frequency, yet positively related to cannabis-related problems. Social
anxiety was related to all AS subfacets and IU, which is consistent with prior work (Allan et al.,
2014; Belcher & Peters, 2009; Boelen & Reijntjes, 2009; Carleton et al., 2010; Grant et al., 2007;
Noel et al., 2013; Norr et al., 2013; Wheaton et al., 2012; Whiting et al., 2014). Consistent with
previous findings (Bonn-Miller, Zvolensky, Marshall, et al., 2007), AS subfacets were unrelated
to cannabis use frequency. Only one known study (Buckner, Zvolensky, et al., 2011) has
examined the associations of AS subfacets with cannabis-related problems and that study found
AS-cognitive concerns to be the only AS subfacet related to cannabis problems. Yet, all AS
subfacets were related to cannabis problems in this sample, with the strongest relationship found
between the AS-social concerns subfacet and cannabis-related problems. AS-social concerns
being the subfacet most related to cannabis problems fits in with prior work given that this
subfacet is most strongly associated with social anxiety (e.g., Allan et al., 2014), which has been
found to be associated with cannabis problems in prior work (for review see Buckner, Heimberg,
et al., 2013). These disparate findings may be accounted for by differences in sample sizes
between the two studies. Correlations between AS subfacets and cannabis-related problems
represented small effect sizes in both studies but our sample consisted of four times as many
participants as that of Buckner and colleagues (2011). Thus, their sample might have been
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underpowered to detect significant correlations between all AS subfacets and cannabis problems,
although effect sizes were similar.
As predicted, IU was not related to cannabis use frequency but was related to cannabisrelated problems. This finding suggests that individuals who are unable to tolerate uncertainty
are not necessarily using cannabis more frequently, but something about their use may be placing
them at risk for experiencing more problems related to their use. It may be that these individuals
rely on cannabis to help manage negative affect associated with IU and therefore continue to use
cannabis despite having problems associated with their use. Further, given that greater IU is
associated with a multitude of anxiety disorder symptoms (Carleton et al., 2010; Carleton et al.,
2014; Carleton et al., 2012), individuals with high IU may be using cannabis to manage the
uncertainty associated with anxiety-provoking situations (e.g., panic attacks, social interactions,
future catastrophic events).
Social anxiety was indirectly related to cannabis problems through AS-social concerns
and IU. However, when these variables were tested simultaneously, social anxiety remained
indirectly related to cannabis problems through IU only. These findings suggest that socially
anxious individuals may be more at risk to develop cannabis-related problems if they perceive
that they are unable to tolerate uncertain situations. These individuals may avoid ambiguous
social situations and engage in more solitary cannabis use, which is associated with more
cannabis-related problems (Creswell, Chung, Clark, & Martin, 2015). These findings point to the
potential utility of these malleable anxiety-related vulnerability factors in intervention efforts
aimed at reducing cannabis-related impairment, especially among socially anxious individuals
who are experiencing problems relate to their use.
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4.2 Limitations and Future Directions
The current study should be interpreted in light of some limitations. First, due to the
cross-sectional nature of this study, causal inferences cannot be made. Prospective and
experimental work examining the role of anxiety-related cognitive vulnerability factors in the
social anxiety-cannabis problems relationship will be an important next step. Second, self-report
measures were used and future work will benefit from utilizing multi-method designs (i.e.,
biological verification of cannabis use, clinical interview to assess social anxiety disorder
symptoms, behavioral measures of AS and IU). Third, the sample consisted of undergraduate
cannabis users who were primarily Caucasian females. Although an undergraduate sample was
warranted given that they seem to be at risk for cannabis-related problems (Caldeira, Arria,
O'Grady, Vincent, & Wish, 2008), future work is needed in more diverse populations. Fourth,
given the small correlations found between anxiety-related vulnerability factors and cannabis
problems, results should be replicated to ensure that these relationships were not spurious.
4.3 Conclusions
Results of the current study suggest that anxiety-related cognitive vulnerability factors
may play a role in cannabis-related impairment, although not necessarily in the frequency of
cannabis use. IU may be particularly important in the relationship between social anxiety and
cannabis-related problems. Thus, given that IU is malleable (Boswell et al., 2013; Dugas &
Ladouceur, 2000; Ladouceur et al., 2000; Mahoney & McEvoy, 2012) it may be ideal to target in
transdiagnostic treatments aimed at treating cannabis use disorders and anxiety disorders
simultaneously (Buckner, Zvolensky, Schmidt, et al., 2014).
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